Moderna, Inc.
0QF.F
Get informed when a big investor buys or sells
+ FollowMarket Cap$75.39B
Close$
Share Statistics
| Market cap | $75.39 Billion |
|---|---|
| Enterprise Value | $75.20 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -46.61% |
|---|---|
| Return on Assets | -28.75% |
| Return on Invested Capital | -38.70% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 33.75 |
| Enterprise Value to EBIT | -23.06 |
| Enterprise Value to Net Income | -24 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Moderna Inc
4,700 employees
CEO: Stephane Bancel Moderna, Inc. is a pioneering biotechnology firm dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) therapeutics and vaccines. Operating across the United States, Europe, and other international market...